Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Neurocognitive Trajectories After BCMA CAR-T in Multiple Myeloma

NCT07740317 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT07740317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07740317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Neurocognitive Trajectories After BCMA CAR-T in Multiple Myeloma
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
November 30, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cart therapy, multiple myeloma (mm), refractory multiple myeloma (rrmm)